The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation

Objective: Where patient level data are available on health care costs, it is natural to use statistical analysis to describe the differences in cost between alternative treatments. Health care costs are, however, commonly considered to be skewed, which could present problems for standard statistical tests. This review examines how authors report the distributional form of health care cost data and how they have analysed their results. Method: A review of cost-effectiveness studies that collected patient-level data on health care costs. To supplement the review, five datasets on health care costs are examined. Consideration is given to the use of parametric methods on the transformed scale and to non-parametric methods of analysing skewed cost data. Results: Since economic analysis requires estimation in monetary units, the usefulness of transformation-based methods is limited by the inability to retransform cost differences to the original scale. Non-parametric rank sum methods were also found to be of limited use for economic analysis, partly due to the focus on hypothesis testing rather than estimation. Overall, the non-parametric approach of bootstrapping was found to offer a useful test of the appropriateness of parametric assumptions and an alternative method of estimation where those assumptions were found not to hold. Conclusions: Guidelines for the analysis of skewed health care cost data are offered.

[1]  J. Pater,et al.  Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Drummond,et al.  Economic Evaluation of A Support Program for Caregivers of Demented Elderly , 1991, International Journal of Technology Assessment in Health Care.

[3]  Maurice G. Kendall,et al.  The Advanced Theory of Statistics. Volume I, Distribution Theory. , 1959 .

[4]  C. Imrie,et al.  Pancreatic necrosis: Assessment of outcome related to quality of life and cost of management , 1993, The British journal of surgery.

[5]  G. Wilkinson,et al.  QALYs in psychiatric care , 1990 .

[6]  G. Raghu,et al.  The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. , 1995, Chest.

[7]  J. Reiffers,et al.  Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission. , 1992, Bone marrow transplantation.

[8]  S. Ridley,et al.  A cost‐utility analysis of intensive therapy , 1994, Anaesthesia.

[9]  A. Wimo,et al.  Impact of day care on dementia patients--costs, well-being and relatives' views. , 1990, Family practice.

[10]  M. Haas Evaluation of physiotherapy using cost-utility analysis. , 1993, The Australian journal of physiotherapy.

[11]  A. Hagenbeek,et al.  Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL). , 1995, Bone marrow transplantation.

[12]  D G Altman,et al.  Statistics Notes: The use of transformation when comparing two means , 1996, BMJ.

[13]  A H Briggs,et al.  Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  L. Schneiderman,et al.  The "abnormal" screening serum thyroxine (T4): analysis of physician response, outcome, cost and health effectiveness. , 1981, Journal of chronic diseases.

[15]  J. Norum,et al.  Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens. , 1995, Journal of chemotherapy.

[16]  M. Mcgrath Cost Effectiveness in Health and Medicine. , 1998 .

[17]  J. Kankaanpää Cost-effectiveness of liver transplantation. , 1987, Transplantation proceedings.

[18]  L. Levin,et al.  Cost-effectiveness of thrombolysis--a randomized study of intravenous rt-PA in suspected myocardial infarction. , 1992, European heart journal.

[19]  J M Bland,et al.  Transforming data. , 1996, BMJ.

[20]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[21]  Bernie J. O'Brien,et al.  In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care , 1994, Medical care.

[22]  A H Briggs,et al.  Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.

[23]  P. Warde,et al.  Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. Welch,et al.  Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. , 1989, The New England journal of medicine.

[25]  C. Morrell,et al.  Cost effectiveness of community leg ulcer clinics: randomised controlled trial , 1998, BMJ.

[26]  D Polsky,et al.  Confidence intervals for cost-effectiveness ratios: a comparison of four methods. , 1997, Health economics.

[27]  H. Cohen,et al.  Costs and effectiveness of a nurse specialist anticoagulant service. , 1997, Journal of clinical pathology.

[28]  L. Green,et al.  Cost-effectiveness of educational interventions to improve patient outcomes in blood pressure control. , 1985, Preventive medicine.

[29]  S. D. Roberts,et al.  Surgery or Angioplasty for Cost-effective Renal Revascularization? , 1987, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  L. Mynors-Wallis,et al.  A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care , 1997, British Journal of Psychiatry.

[31]  R. Chaisson,et al.  Zidovudine therapy and health resource utilization in AIDS. , 1994, Journal of acquired immune deficiency syndromes.

[32]  J. Richardson,et al.  A cost utility analysis of treatment options for gallstone disease: methodological issues and results. , 1994, Health economics.

[33]  N. Blomqvist,et al.  Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1998, Statistics in medicine.

[34]  A. Laupacis,et al.  Total hip replacement: the case for noncemented femoral fixation because of age. , 1995, Canadian journal of surgery. Journal canadien de chirurgie.

[35]  P Fenn,et al.  The Analysis of Censored Treatment Cost Data in Economic Evaluation , 1995, Medical care.

[36]  A M Gray,et al.  The Oxford Laser Prostate Trial: economic issues surrounding contact laser prostatectomy. , 1996, British journal of urology.

[37]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[38]  Douglas G. Altman,et al.  Statistics Notes: Transforming data , 1996 .

[39]  A H Briggs,et al.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.

[40]  M. Johannesson,et al.  The cost‐effectiveness of treating hypertension in elderly people—an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension) , 1993, Journal of internal medicine.

[41]  J. Mauskopf,et al.  Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charges. , 1995, The Journal of pediatrics.

[42]  K. Tolley,et al.  An economic evaluation of home‐care assistance for AIDS patients: a pilot study in a town in northern Italy , 1992, AIDS.

[43]  P. Armitage,et al.  Statistical methods in medical research. , 1972 .

[44]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[45]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[46]  L. Påhlman,et al.  Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  G W Torrance,et al.  Economic evaluation of neonatal intensive care of very-low-birth-weight infants. , 1983, The New England journal of medicine.

[48]  I. L. Cohen,et al.  Mechanical ventilation for the elderly patient in intensive care. Incremental changes and benefits. , 1993, JAMA.

[49]  K. Gournay,et al.  The community psychiatric nurse in primary care: an economic analysis. , 1995, Journal of advanced nursing.

[50]  R. Green,et al.  Economic implications of thrombolysis or operation as the initial treatment modality in acute peripheral arterial occlusion. , 1995, Surgery.

[51]  D G Altman,et al.  Statistics notes: Transformations, means, and confidence intervals , 1996, BMJ.

[52]  J. Allen,et al.  The costs and benefits of bone marrow transplantation. , 1991, The New Zealand medical journal.

[53]  G. Guyatt,et al.  Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. , 1994, The American journal of cardiology.